NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

TRIPS and Rights: Access to medicines, international human rights law, and the interpretation of the WTO treaty on intellectual property rights.

Elliott R; International Conference on AIDS.

Int Conf AIDS. 2002 Jul 7-12; 14: abstract no. G12627.

Canadian HIV/AIDS Legal Network, Toronto, Canada

ISSUES: People and countries with scarce resources need affordable medicines. Strict patent laws keep drug prices high. The Agreement on Trade-Related Aspects of Intellectual Property Rights ("TRIPS") sets out minimum patent law requirements for World Trade Organization (WTO) member countries. States have binding obligations under international human rights (IHR) law to progressively realize each person's right to the highest attainable standard of health. But political negotiations, and decisions of WTO tribunals, have given scant consideration to IHR law in interpreting and applying TRIPS. DESCRIPTION: A paper examined the sources of international law such as treaties (eg, UN Charter and IHR conventions), customary international law (eg, Universal Declaration of Human Rights), and legal doctrine (judicial decisions and teachings of experts such as General Comments of UN Committee on Economic, Social & Cultural Rights). The paper outlined the status of the right to health in international law and analysed the relationship between IHR law and trade agreements. The paper applied established rules of treaty interpretation to determine the correct interpretation of TRIPS. LESSONS LEARNED: States' human rights obligations have primacy in international law. Therefore, TRIPS must be interpreted consistent with these obligations. Where this is not possible, States' obligations under TRIPS must be recognized as non-binding to the extent of the conflict with IHR law. RECOMMENDATIONS: States should formally recognize the primacy of their human rights obligations, through a clear WTO Ministerial Declaration. In interpreting TRIPS, WTO tribunals must prefer any reasonable interpretation consistent with States' human rights obligations. TRIPS should be amended to state the primacy of States' human rights obligations, and to recognize the non-binding nature of clauses that require States to act in breach of their obligations under IHR law.

Publication Types:
  • Meeting Abstracts
Keywords:
  • Commerce
  • Drugs, Essential
  • Drugs, Generic
  • Health
  • Human Rights
  • Humans
  • Intellectual Property
  • International Cooperation
  • Legislation
  • Organizations
  • Ownership
  • Patents
  • Pharmaceutical Preparations
  • Research
  • United Nations
  • legislation & jurisprudence
Other ID:
  • GWAIDS0013050
UI: 102250548

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov